Finviz is one of those tools that everyone in retail investing seems to discover in year one. You open it expecting a stock table, and instead get a heatmap, a screener with 60+ filters, and a news feed — all fast, all free. The learning curve is basically zero.
So what does the investing community actually think of it in 2025? We went through hundreds of threads across r/investing, r/stocks, r/ValueInvesting, r/eupersonalfinance, and r/EuropeanStocks to find out.
The consensus: fast, good for US stocks, hits a wall quickly
The most common Finviz opinion on Reddit is a backhanded compliment: "it's the best free tool for US stocks."
That qualifier — for US stocks — comes up constantly. And it reveals the central tension in how experienced investors relate to Finviz. It's excellent in a specific lane. Outside that lane, it doesn't exist.
What Reddit likes about Finviz
Speed, above everything else. Users consistently describe Finviz as the fastest screener they've used. Results update instantly, the interface doesn't lag, and the heatmap loads without a spinner. For a free web tool, this is not a given.
The heatmap. This comes up in almost every positive discussion. The ability to see the entire US market — color-coded by performance, grouped by sector — in a single glance is genuinely useful. It's become a morning ritual for many retail investors.
The screener depth. 67 fundamental, technical, and descriptive filters is a lot. P/E, P/B, EV/EBITDA, debt/equity, dividend yield, short float, 52-week range, RSI, average volume — all filterable, all fast, all in one table.
The price. The free tier is substantial. You can build a useful screening workflow without paying anything.
"Finviz for a quick scan of the US market, then TradingView for charts. Best free combo out there." — r/stocks
What Reddit criticizes
Here's where the threads get more honest.
The data delay on free accounts
Free users get data delayed 15–20 minutes depending on the exchange. This isn't a problem for position investors doing end-of-day screening. It's a dealbreaker for anyone trying to act on intraday moves. The elite tier fixes this, but at $39.99/month (or ~$300/year on annual), the price feels steep relative to what else is available.
Weak fundamental depth
Finviz shows the basics: P/E, P/B, EPS, revenue, short float. What it doesn't show: the Graham Number, Piotroski F-Score, multi-year financial trend data, earnings transcripts, or SEC filings. For a value investor trying to build a systematic scoring system, these gaps matter.
"Finviz gets you to the shortlist. Then you need three other tools to actually research the companies." — r/ValueInvesting
No European stocks
This is the biggest complaint among non-US investors — and it comes up constantly in European investing threads.
Finviz indexes roughly 8,000–10,000 stocks, nearly all of them US-listed. European companies appear only if they have a US ADR or cross-listing. For investors trying to screen native listings on XETRA, Euronext, BME, or Borsa Italiana, Finviz is essentially useless.
"I love Finviz but I invest mainly in European stocks and it just doesn't work for that." — r/eupersonalfinance
"Someone please build a Finviz for European stocks." — r/EuropeanStocks
This gap is significant. European markets — especially mid and small caps — are where many serious investors look for inefficiency. A screener that doesn't cover them forces European investors to patch together multiple inferior tools.
No mobile app
Finviz is web-only. There's no native mobile app for iOS or Android. For a tool used this widely, that's a surprising omission in 2026. Not a dealbreaker for desktop investors, but it comes up frequently.
Fragmented workflow
Even fans of Finviz describe leaving it constantly: to TradingView for charts, to Macrotrends or Wisesheets for historical data, to SEC EDGAR for filings. The screener finds candidates; everything else happens somewhere else. This fragmentation is a recurring frustration.
The charting gap
Finviz has charts, but they're static and not customizable in any meaningful way. No Pine Script, no drawing tools, no multi-timeframe view. TradingView has made chart quality a table-stakes expectation, and Finviz's charts fall short of it.
What investors switch to
When Reddit threads ask "what do you use instead of Finviz?" the answers cluster around a few tools depending on the use case:
TradingView — the most common switch, primarily for charting. Its screener also covers 60,000+ stocks across global exchanges, which solves the international coverage problem. The free tier is limited; serious use requires a paid plan.
TIKR — frequently mentioned for global fundamental research. Covers 100,000+ companies across 130+ countries with 20+ years of financial history. More of a research tool than a screener; the interface prioritizes depth over speed.
Stock Rover — the preferred alternative for US-focused value investors who want deeper fundamental data. 650+ metrics, research reports, portfolio tracking. Not as fast as Finviz.
ScreenerHero — mentioned specifically in European investing threads as the alternative that actually covers European exchanges. Screens 17,000+ stocks across the US, Canada, and European markets — including XETRA, Euronext Paris, BME, and Borsa Italiana — with fundamental filters, a heatmap, and a Finviz-style dense interface. For investors who want the Finviz experience extended to European markets, this is the most direct equivalent.
Koyfin — preferred for global macro and multi-asset research. Covers 100,000+ global companies with strong charting and dashboard capabilities. Better for analysis than quick screening.
How Finviz compares to its main alternatives
| Feature | Finviz | ScreenerHero | TradingView | TIKR Pro | Stock Rover |
|---|---|---|---|---|---|
| US stocks | ✓ (best in class) | ✓ | ✓ | ✓ | ✓ |
| European stocks | ✗ | ✓ (all exchanges) | Large cap only | Inconsistent | ✗ |
| Canadian stocks | ✗ | ✓ TSX | ✓ | Partial | ✓ TSX |
| Free no-account tier | ✓ | ✓ | ✗ (requires account) | ✗ | ✗ |
| Fundamental filters | P/E, P/B, EV/EBITDA | P/E, P/B, EV/EBITDA, ROE | Partial on free | Full (paid) | 650+ metrics |
| Historical data | Limited | EOD only | Limited | 20 years (Pro) | 10 years |
| Paid price/mo | $39.50 Elite | €29 Pro | $15–60 | $40–55 Pro | $7.99–28 |
Frequently asked questions
Is Finviz worth it in 2026?
For US-only investors: yes, Finviz is still one of the best free screening tools available, and Finviz Elite at $39.50/month is competitive. For investors who include European or Canadian stocks in their workflow, Finviz has a fundamental limitation — it simply doesn't cover those markets. The answer depends almost entirely on your geographic scope.
What do Reddit users recommend as a Finviz alternative for European stocks?
ScreenerHero is consistently recommended in r/eupersonalfinance and r/EuropeanStocks threads as the most direct equivalent to Finviz for European markets. It covers XETRA, Euronext Paris, BME, Borsa Italiana, and alternative markets (Euronext Growth, First North, EGM), has a similarly dense interface, and the free tier requires no account — matching Finviz's no-signup policy.
Can Finviz screen European stocks?
No. Finviz covers US-listed equities only (NYSE, NASDAQ, NYSE American, OTC). European companies appear only if they have a US ADR listing — native European exchange listings (XETRA, Euronext, BME, Borsa Italiana, etc.) are not in the Finviz universe.
What is the best free stock screener for European stocks?
ScreenerHero is the best free stock screener for European stocks — full screener access, no account required, covering all major European exchanges including alternative markets. Finviz is the equivalent for US stocks. For investors covering both markets, ScreenerHero covers both US and European markets in one tool.
Why doesn't Finviz add European stocks?
Finviz has been US-focused since its founding and has not publicly stated plans to expand to European markets. Adding European coverage requires sourcing data from 14+ exchanges across multiple countries, each with different data formats, reporting timelines, and licensing arrangements — a significant infrastructure investment. Finviz's US-only positioning appears intentional rather than an oversight.
The honest verdict
Finviz is a well-built tool that does exactly what it was designed to do: help US retail investors screen US stocks quickly and for free. In that lane, it's still one of the best options available.
The complaints on Reddit aren't really complaints about Finviz being bad. They're complaints about investors outgrowing what Finviz was designed for: wanting global coverage, deeper fundamentals, better charts, and a more complete workflow.
If you're a US-focused investor doing end-of-day screening, Finviz probably still works fine. If you invest in European markets, need value-investing metrics beyond P/E and P/B, or want charts and research in the same tool, you'll hit its ceiling quickly.
That ceiling is well-documented on Reddit. The question is whether you notice it before or after you've built a workflow around it.